使用仿真VSV-NDV的瘤性病毒疗法协同支持RIG-I依赖检查点抑制剂免疫疗法
Janina Marek1, Lorenz Hanesch1, Teresa Krabbe1
1Department of Internal Medicine II, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
Molecular therapy oncolytics
|September 1, 2023
概括
结合一个模拟性瘤性病毒 (VSV-NDV) 与抗细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 疗法显示出有前途. 这种组合会延缓瘤生长,并通过激活瘤细胞中的RIG-I信号来提高生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 瘤微环境 (TME) 调制是克服免疫疗法耐药性的关键.
- 网红酸诱导基因-I (RIG-I) 向可以将"冷"瘤转化为炎症",热"病变,增强抗细胞毒性T淋巴细胞相关蛋白4 (CTLA-4) 的疗效.
- 化学解病毒提供了一种激发抗瘤免疫力的策略.
研究的目的:
- 为了研究一种仿真囊泡性口腔炎病毒 (VSV) - - 纽卡斯尔病病毒 (NDV) 与抗CTLA-4疗法结合的疗效.
- 确定RIG-I信号在调解VSV-NDV和抗CTLA-4的协同效应中的作用.
- 评估RIG-I依赖的性病毒疗法的潜力,使瘤对免疫检查点抑制产生敏感性.
主要方法:
- 使用了一种恶性黑色素瘤的小鼠模型.
- 单独使用VSV-NDV以及与抗CTLA-4药物联合使用.
- 评估了瘤生长延迟,生存率和依赖RIG-I的免疫反应.
- 分析了VSV-NDV的直接瘤学和促炎作用.
主要成果:
- 单独使用VSV-NDV治疗可以延缓瘤生长和延长存活时间.
- 与VSV-NDV和抗CTLA-4联合治疗表明增强了抗瘤作用.
- 组合疗法的协同效应严重依赖于瘤细胞中的RIG-I信号.
- 对VSV-NDV的直接性和促炎作用是RIG-I独立的.
结论:
- VSV-NDV是一种强大的免疫刺激性瘤病毒,可以使瘤对抗CTLA-4疗法的敏感.
- 瘤细胞内的RIG-I激活对于VSV-NDV和抗CTLA-4的协同效果至关重要.
- 这种组合策略具有增强抗瘤免疫力和克服对免疫检查点抑制剂耐药性的治疗潜力.
相关概念视频
Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Cancer Vaccines
400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


